The patent is being accelerated since it is a biomedical device and when patents are accelerated what would take years is done around 6 months. And so anyone looking for news may be waiting until around March of 2022... that's when the Art device will hit 6 months since patent submission.

I think this can profoundly raise the share price above 10 as it then begins its one year journey for FDA approval as it will probably be fast tracked through if all goes well. (I dont see any reason to not fast track through the FDA unless it makes people extremely ill, terrible side effects, or causes death and that is where the risk of an investment will be). Anyway...

the only reason right now this will stay around 4 - 10 dollars is risk of FDA denial as I think the patent will go through without much of a hitch. I mean the only way it will fail patent approval is if another device is found doing the same thing or hidden by the big mechanical ventilation companies that stand to lose billions if this device comes out. Any thoughts... I think its a hold for the long run. I think the patent will be approved and it will pass FDA approval within the year like the developers are saying... and when it comes to the developers, we are not talking about a couple of hoots banging something out in the garage... we are talking about geniuses in the medical fields of respiratory care that know whats already out there and what is really needed now with the technology we have. I think this might even be considered a seminal patent in the field of forced oxygenation... the whole field will be redefined.$Inspira Technologies Oxy B.H.N. Ltd.(IINN)$